Jeremy M. Aymard

Jeremy M. Aymard

Auto-generated profile, based on publicly available information

Jeremy M. Aymard

Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Abdallah Sherif Radwan MohamedAbdallah Sherif Radwan Mohamed
Abdallah Sherif Radwan Mohamed
HEHesham Elhalawani
Hesham Elhalawani
AKAasheesh Kanwar
Aasheesh Kanwar
Abdallah Sherif Radwan MohamedAbdallah Sherif Radwan Mohamed
Abdallah Sherif Radwan Mohamed
AWAubrey White
Aubrey White
CFClifton David Fuller
Clifton David Fuller
Radiomics is one such “big data” approach that applies advanced image refining/data characterization algorithms to generate imaging features that can quantitatively classify tumor phenotypes in a non-invasive manner. We hypothesize that certain textural features of oropharyngeal cancer (OPC) primary tumors will have statistically significant correlations to patient outcomes such as local control. Patients from an IRB-approved database dispositioned to (chemo)radiotherapy for locally advanced OPC were included in this retrospective series. Pretreatment contrast CT scans were extracted and radiomics-based analysis of gross tumor volume of the primary disease (GTVp) were performed using imaging biomarker explorer (IBEX) software that runs in Matlab platform. Data set was randomly divided into a training dataset and test and tuning holdback dataset. Machine learning methods were applied to yield a radiomic signature consisting of features with minimal overlap and maximum prognostic significance. The radiomic signature was adapted to discriminate patients, in concordance with other key clinical prognosticators. 465 patients were available for analysis. A signature composed of 2 radiomic features from pre-therapy imaging was derived, based on the Intensity Direct and Neighbor Intensity Difference methods. Analysis of resultant groupings showed robust discrimination of recurrence probability and Kaplan-Meier-estimated local control rate (LCR) differences between “favorable” and “unfavorable” clusters were noted.

4 July 2017 in Scientific Data
Verified
Journal Article
Open access
PDF file
MHMiccai/M.D. Anderson Cancer Center Head
Miccai/M.D. Anderson Cancer Center Head
NGNeck Quantitative Imaging Working Group
Neck Quantitative Imaging Working Group
HEHesham Elhalawani
Hesham Elhalawani
Abdallah Sherif Radwan MohamedAbdallah Sherif Radwan Mohamed
Abdallah Sherif Radwan Mohamed
AWAubrey L. White
Aubrey L. White
CFClifton David Fuller
Clifton David Fuller
Cancers arising from the oropharynx have become increasingly more studied in the past few years, as they are now epidemic domestically. These tumors are treated with definitive (chemo)radiotherapy, and have local recurrence as a primary mode of clinical failure. Recent data suggest that ‘radiomics’, or extraction of image texture analysis to generate mineable quantitative data from medical images, can reflect phenotypes for various cancers. Several groups have shown that developed radiomic signatures, in head and neck cancers, can be correlated with survival outcomes. This data descriptor defines a repository for head and neck radiomic challenges, executed via a Kaggle in Class platform, in partnership with the MICCAI society 2016 annual meeting.These public challenges were designed to leverage radiomics and/or machine learning workflows to discriminate HPV phenotype in one challenge (HPV status challenge) and to identify patients who will develop a local recurrence in the primary tumor volume in the second one (Local recurrence prediction challenge) in a segmented, clinically curated anonymized oropharyngeal cancer (OPC) data set.

17 August 2018 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
HEHesham Elhalawani
Hesham Elhalawani
TLTimothy A Lin
Timothy A Lin
SVStefania Volpe
Stefania Volpe
Abdallah Sherif Radwan MohamedAbdallah Sherif Radwan Mohamed
Abdallah Sherif Radwan Mohamed
AWAubrey L White
Aubrey L White
CFClifton David Fuller
Clifton David Fuller
Radiomics leverages existing image datasets to provide non-visible data extraction via image post-processing, with the aim of identifying prognostic, and predictive imaging features at a sub-region of interest level. However, the application of radiomics is hampered by several challenges such as lack of image acquisition/analysis method standardization, impeding generalizability. As of yet, radiomics remains intriguing, but not clinically validated. We aimed to test the feasibility of a non-custom-constructed platform for disseminating existing large, standardized databases across institutions for promoting radiomics studies. Hence, University of Texas MD Anderson Cancer Center organized two public radiomics challenges in head and neck radiation oncology domain. This was done in conjunction with MICCAI 2016 satellite symposium using Kaggle-in-Class, a machine-learning and predictive analytics platform. We drew on clinical data matched to radiomics data derived from diagnostic contrast-enhanced computed tomography (CECT) images in a dataset of 315 patients with oropharyngeal cancer. Contestants were tasked to develop models for (i) classifying patients according to their human papillomavirus status, or (ii) predicting local tumor recurrence, following radiotherapy. Data were split into training, and test sets. Seventeen teams from various professional domains participated in one or both of the challenges. This review paper was based on the contestants' feedback; provided by 8 contestants only (47%). Six contestants (75%) incorporated extracted radiomics features into their predictive model building, either alone (n = 5; 62.5%), as was the case with the winner of the “HPV” challenge, or in conjunction with matched clinical attributes (n = 2; 25%). Only 23% of contestants, notably, including the winner of the “local recurrence” challenge, built their model relying solely on clinical data. In addition to the value of the integration of machine learning into clinical decision-making, our experience sheds light on challenges in sharing and directing existing datasets toward clinical applications of radiomics, including hyper-dimensionality of the clinical/imaging data attributes. Our experience may help guide researchers to create a framework for sharing and reuse of already published data that we believe will ultimately accelerate the pace of clinical applications of radiomics; both in challenge or clinical settings.

9 September 2017 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
MGMD Anderson Head and Neck Cancer Symptom Working Group
MD Anderson Head and Neck Cancer Symptom Working Group
SESalman A. Eraj
Salman A. Eraj
Mona K. JomaaMona K. Jomaa
Mona K. Jomaa
CRCrosby D. Rock
Crosby D. Rock
Abdallah Sherif Radwan MohamedAbdallah Sherif Radwan Mohamed
Abdallah Sherif Radwan Mohamed
GGG. Brandon Gunn
G. Brandon Gunn
Given the potential for older patients to experience exaggerated toxicity and symptoms, this study was performed to characterize patient reported outcomes in older patients following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). Cancer-free head and neck cancer survivors (>6 months since treatment completion) were eligible for participation in a questionnaire-based study. Participants completed the MD Anderson Symptom Inventory-Head and Neck module (MDASI-HN). Those patients ≥65 years old at treatment for OPC with definitive RT were included. Individual and overall symptom severity and clinical variables were analyzed. Of the 79 participants analyzed, 82% were male, 95% white, 41% T3/4 disease, 39% RT alone, 27% induction chemotherapy, 52% concurrent, and 18% both, and 96% IMRT. Median age at RT was 71 yrs. (range: 65–85); median time from RT to MDASI-HN was 46 mos. (2/3 > 24 mos.). The top 5 MDASI-HN items rated most severe in terms of mean (±SD) ratings (0–10 scale) were dry mouth (3.48 ± 2.95), taste (2.81 ± 3.29), swallowing (2.59 ± 2.96), mucus in mouth/throat (2.04 ± 2.68), and choking (1.30 ± 2.38) reported at moderate-severe levels (≥5) by 35, 29, 29, 18, and 13%, respectively. Thirty-nine % reported none (0) or no more than mild (1–4) symptoms across all 22 MDASI-HN symptoms items, and 38% had at least one item rated as severe (≥7). Hierarchical cluster analysis resulted in 3 patient groups: 1) ~65% with ranging from none to moderate symptom burden, 2) ~35% with moderate-severe ratings for a subset of classically RT-related symptoms (e.g. dry mouth, mucus, swallowing) and 3) 2 pts. with severe ratings of most items. The overall long-term symptom burden seen in this older OPC cohort treated with modern standard therapy was largely favorable, yet a higher symptom group (~35%) with a distinct pattern of mostly local and classically RT-related symptoms was identified.

1 January 2018 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
MKMona Kamal
Mona Kamal
DRDavid I. Rosenthal
David I. Rosenthal
SVStefania Volpe
Stefania Volpe
RGRyan Goepfert
Ryan Goepfert
AGAdam S. Garden
Adam S. Garden
GGG. Brandon Gunn
G. Brandon Gunn

1 April 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Mona K. JomaaMona K. Jomaa
Mona K. Jomaa
DRDavid I. Rosenthal
David I. Rosenthal
ABAakash Batra
Aakash Batra
SVStefania Volpe
Stefania Volpe
BEBaher Elgohari
Baher Elgohari
GGG. Brandon Gunn
G. Brandon Gunn